Forsiden ENOVA

Group photo from 2nd enova workshop

ENOVA is a science and technology “Network on Vaccine Adjuvants”, funded by COST through the EU Framework Programme Horizon 2020. ENOVA is coordinated by the Vaccine Formulation Institute (UK) and brings together European experts and stakeholders working in different areas of adjuvant and vaccine R&D, including both prophylactic and therapeutic applications as well as human and veterinary vaccines.  ENOVA’s members include industry, academic, and government institutions. The ultimate goals of the network are to facilitate communication and the exchange of information among its membership, to ensure that new discoveries are widely disseminated so that their potential can be of optimal benefit, to promote the best use of existing adjuvant technologies, and to encourage and support the development of novel adjuvants.

Log in (restricted)

News

  • New Call for training modules. Deadline 1 July 2019 June 13, 2019 10:18 AM

    TRANSVAC: European Training in Vaccinology

    M10 - Assay Development and Validation-Application of SPR Technologies in Vaccine development and manufacturing.

    Venue: Fraunhofer IME, Aachen Germany

    Date: 10-11 October 201 9

    M11 - Process Development and scale-up of recombinant protein vaccines.

    Venue: Fraunhofer IME, Aachen Germany

    Date: 7-8 October 201 9

    M12 - Requirements for GMP production

    Venue: Fraunhofer IME, Aachen Germany

    Date: 14-15 October 201 9

  • 6th Call for TRANSVAC Vaccine Development Services (TNA) - deadline 5 August 2019 June 13, 2019 10:14 AM

    TRANSVAC2 project offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use. These services are not restricted to any disease in particular.

    Except for the few cases indicated on the website, services will be offered free of charge!

    Academic and non-academic research groups, SMEs and industries can apply but only to service infrastructures outside their own country.

  • Webinar: 'Towards a GDPR Code of Conduct for Health Research: where are we today?' June 5, 2019 4:04 PM
  • TRANSVAC: European Training in Vaccinology May 8, 2019 4:22 PM

    The fourth call is open from 1 April 2019 – 1 st June 2019. It covers 3 modules:

    • M6 - CyTOF conducted at CEA, Fontenay-aux-Roses, France (19-20 September 2019)
    • M7 - Flow Cytometry organized also by CEA, Fontenay-aux-Roses, France (18-19 September 2019)
    • M9 - Key considerations and best practices for viral vaccine process development, scale-up and implementation at manufacturing scale including single use technologies, organized by VFI together with Merck at Merck/M Lab permises in Molsheim, France (10-11 September 2019)

Events